BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

InVitria Achieves cGMP Qualification Milestone


2/8/2011 11:27:26 AM

Fort Collins, CO, USA, February 8, 2011 / b3c newswire / – InVitria announces that its Lysobac cell lysing reagent is manufactured at the Company’s Junction City, Kansas facility under cGMP (Current Good Manufacturing Practice) standards. Lysobac is a completely animal component free reagent that is substantially more effective and consistent than hen egg white lysozyme and complies with global regulatory standards for manufacturing biotherapeutics.

“Achievement of this milestone demonstrates InVitria’s commitment to the high quality standards that our customers expect,” said Shawn Smith, Vice President of Sales & Marketing.

“Customers routinely inspect our facility and operations as part of their normal purchasing and vendor qualification process. With the introduction of cGMP-grade Lysobac, we are raising the bar for the quality of reagents used in biomanufacturing,” said Greg Unruh, Vice President of Manufacturing.

InVitria’s Lysobac is used in the manufacture of several products derived from microbial fermentation such as E. coli. Lysobac is more than four times more effective than hen egg white lysozyme and because it is derived from recombinant production, it is delivers consistent performance. For more information about Lysobac, please visit www.Lysobac.com . All biomanufacturing products from InVitria are animal component free and manufactured in Kansas. They include cell culture media supplements that optimize performance of cell lines including CHO, hybridoma, Vero, MDCK, mesenchymal, pluripotent, keratinocyte, chondrocyte and a wide array of stem and primary cell lines.

About InVitria - www.invitria.com

InVitria develops, manufactures and markets a portfolio of products used in cell culture, diagnostics and bioproduction. InVitria’s products address customer needs for defined, animal component free cell culture supplements in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines and general life science research.

To obtain more information about InVitria’s product solutions, e-mail info@InVitria.com , visit us online at www.InVitria.com , or call toll-free 1-800-916-8311


Read at BioSpace.com


InVitria
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->